Cargando…

Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer that is characterized by its poor prognosis, rapid progression and development of drug resistance. Chemotherapy is a vital treatment option for most of PDAC patients. Stratification of PDAC patients, who would have a higher likel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Hong, Chen, Ru, Brentnall, Teresa A., Eng, Jimmy K., Picozzi, Vincent J., Pan, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636003/ https://www.ncbi.nlm.nih.gov/pubmed/31346328 http://dx.doi.org/10.1186/s12014-019-9251-3

Ejemplares similares

Proteome alterations in pancreatic ductal adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2020)

Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients
por: Peng, Hong, et al.
Publicado: (2020)

Proteomics Portrait of Archival Lesions of Chronic Pancreatitis
por: Pan, Sheng, et al.
Publicado: (2011)

Glycoproteins and glycoproteomics in pancreatic cancer
por: Pan, Sheng, et al.
Publicado: (2016)

Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Gwark, Sungchan, et al.
Publicado: (2021)

Proteome heterogeneity and malignancy detection in pancreatic cyst fluids
por: Pan, Sheng, et al.
Publicado: (2021)

An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer
por: Lin, Hongcao, et al.
Publicado: (2021)

Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia
por: Chen, Ru, et al.
Publicado: (2010)

An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
por: Qi, Lishuang, et al.
Publicado: (2016)

Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy
por: Ishii, Noriko, et al.
Publicado: (2020)

Biomarkers for colitis-associated colorectal cancer
por: Chen, Ru, et al.
Publicado: (2016)

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
por: Chen, Ru, et al.
Publicado: (2017)

Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer
por: Zhuo, Zewei, et al.
Publicado: (2022)

Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021)

A novel natural killer cell-related signatures to predict prognosis and chemotherapy response of pancreatic cancer patients
por: Lan, Yongting, et al.
Publicado: (2023)

Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells
por: Senavirathna, Lakmini, et al.
Publicado: (2021)

Quantitative Glycoproteomics Analysis Reveals Changes in N-Glycosylation Level Associated with Pancreatic Ductal Adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2014)

High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer
por: Ye, Shu-Biao, et al.
Publicado: (2023)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
por: Wu, Jin, et al.
Publicado: (2022)

A proteomic signature that reflects pancreatic beta-cell function
por: Curran, Aoife M., et al.
Publicado: (2018)

The advanced lung cancer inflammation index predicts chemotherapy response and infection risk in multiple myeloma patients receiving induction chemotherapy
por: Cheng, Jie, et al.
Publicado: (2022)

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
por: Dong, Jie, et al.
Publicado: (2021)

The Evaluation of Magee Equation 2 in Predicting Response and Outcome in Hormone Receptor-Positive and HER2-Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Saigosoom, Napat, et al.
Publicado: (2020)

Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients
por: Mo, Xianwei, et al.
Publicado: (2020)

Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer
por: Muranaka, Hayato, et al.
Publicado: (2023)

Arousal of Cancer-Associated Stroma: Overexpression of Palladin Activates Fibroblasts to Promote Tumor Invasion
por: Brentnall, Teresa A., et al.
Publicado: (2012)

A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia
por: Gong, Han, et al.
Publicado: (2022)

The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy
por: Baig, Jalal, et al.
Publicado: (2019)

The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
por: Chauvin, Anaïs, et al.
Publicado: (2018)

Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma
por: Chen, Ru, et al.
Publicado: (2014)

Seven-Signal Proteomic Signature for Detection of Operable Pancreatic Ductal Adenocarcinoma and Their Discrimination from Autoimmune Pancreatitis
por: Yanagisawa, Kiyoshi, et al.
Publicado: (2012)

An Immune-Associated Genomic Signature Effectively Predicts Pathologic Complete Response to Neoadjuvant Paclitaxel and Anthracycline-Based Chemotherapy in Breast Cancer
por: Fu, Changfang, et al.
Publicado: (2021)

Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients
por: van der Sijde, Fleur, et al.
Publicado: (2019)

Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
por: Ahmed, Nuzhat, et al.
Publicado: (2016)

Plasma proteomic signatures predict dementia and cognitive impairment
por: Tanaka, Toshiko, et al.
Publicado: (2020)

Proteomic signature of tubulointerstitial tissue predicts prognosis in IgAN
por: Paunas, Flavia Teodora Ioana, et al.
Publicado: (2022)

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer
por: Zhang, Jinbao, et al.
Publicado: (2022)

Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer
por: Hue, Jonathan J., et al.
Publicado: (2021)

Factors influencing spiritual wellbeing among pancreatic ductal adenocarcinoma patients receiving chemotherapy
por: Wei, Ling-Ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8c7m7ftc1hqa20e5dugovuh46v